Eluminex Biosciences’ Acquisition of Zuretinol Acetate Assets from Retinagenix

Goodwin Procter advised Eluminex Biosciences on the deal.Eluminex Biosciences (Suzhou) Limited (Eluminex) announced its acquisition of certain assets and the related global development and commercialization rights for…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now